surpass tirzepatide 💡 New insight in diabetes care: In patients with T2DM and ASCVD, the SURPASS-CVOT trial found that was noninferior to dulaglutide for major cardiovascular events (12.2% vs 13.1%; HR 0.92). What Tirzepatide Matches Dulaglutide in Large

Reddy's Laboratories halted production of new generic semaglutide batches due to impurities in the synthetic active ingredient

Structured programs providing regular contact with healthcare professionals, self-monitoring tools, and behavioral strategies show superior outcomes compared to general advice alone

Wegovy is proven to be effective when taken alongside a diet and exercise plan that involves eating fewer calories and choosing healthier food options

These medications work by mimicking the incretin hormone GLP-1, enhancing glucose-dependent insulin secretion, suppressing glucagon release, slowing gastric emptying, and reducing appetite through central nervous system pathways

One of my patients, Sarah, struggled with obesity for years